• Myriad Genetics Inc

320 Wakara Way
Salt Lake City, UT 84108
United States

Website Investor relation




Price

  • Last Close
  • $ 23.08 0 % -0.66
    Mar 17, 2023
  • Trading Volume
  • 1,675,332
  • 52-Week High/Low
  • $36.66 - $16.45

  • Market Cap Full
  • $ 1.9B
  • YTD
  • 59%
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Q1 27.8% -8.7% 53.6% -5% 14.2% -14% 15.2% -13.3% 3.9% 63%
Q2 - -27.9% 1.2% 4% -16.9% 28.2% 34.6% -18.3% -4% 13.8%
Q3 - 5% 5.6% 8% 3% 22% 40% -32.8% 10.3% -0.9%
Q4 - -24% -14.5% 50.9% -5.2% -34.9% -6.6% -19% 15.2% -11.7%
J F M A M J J A S O N D
2023 35.9% -7.8% - - - - - - - - - -
2022 -6.1% -5.1% 2.4% -18.7% -6.2% -5.6% 45.2% -15.1% -14.9% 8.7% -2.3% -28.4%
    2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
    59%-47%40%-27%-8%-15%106%-61%27%62%-23%

Earnings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Q1 -0.52 -1.55 0.09 0.13 0.27 0.41 0.40 0.21 0.68 0.36
Q2 -0.06 -0.75 -0.05 0.14 0.30 0.36 0.41 0.32 0.66 0.42
Q3 0.3 -0.2 -0.28 -0.01 0.26 0.23 0.41 0.48 0.46 0.34
Q4 - - -0.11 0.03 0.31 0.26 0.45 0.43 0.53 0.34
A -0.6

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume